Evolent Health
EVH
240 hedge funds and large institutions have $3.62B invested in Evolent Health in 2023 Q1 according to their latest regulatory filings, with 43 funds opening new positions, 88 increasing their positions, 72 reducing their positions, and 33 closing their positions.
31% more capital invested
Capital invested by funds: $2.76B → $3.62B (+$855M)
30% more first-time investments, than exits
New positions opened: 43 | Existing positions closed: 33
22% more repeat investments, than reductions
Existing positions increased: 88 | Existing positions reduced: 72
4% more funds holding
Funds holding: 231 → 240 (+9)
3.51% more ownership
Funds ownership: 97.19% → 100.7% (+3.5%)
0% more funds holding in top 10
Funds holding in top 10: 8 → 8 (0)
57% less call options, than puts
Call options by funds: $3.01M | Put options by funds: $6.96M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$316M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
+$37.6M |
| 3 |
ITP
Iron Triangle Partners
Cos Cob,
Connecticut
|
+$31.6M |
| 4 |
FCM
Farallon Capital Management
San Francisco,
California
|
+$26.6M |
| 5 |
TGA
TPG GP A
Fort Worth,
Texas
|
+$24.1M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
-$93.7M |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$36.8M |
| 3 |
BlackRock
New York
|
-$24.5M |
| 4 |
EC
Engaged Capital
Newport Beach,
California
|
-$18.1M |
| 5 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$17.3M |
EVH Hedge Fund Activity: Q1 2023 in Review
240 of the 6,283 institutional investors tracked by Wall St. Rank reported a position in Evolent Health (EVH) for Q1 2023, worth a combined $3.62B — up 31% from $2.76B a quarter earlier.
Buyers outnumbered sellers: 43 funds opened new EVH positions and 33 closed out — a net gain of 10 holders — while 88 added to existing stakes and 72 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $316M. The largest seller was Point72 Asset Management, cutting an estimated $93.7M.
- 240 institutional investors held Evolent Health (EVH) as of Q1 2023, up from 231 in Q4 2022.
- Funds reported $3.62B of Evolent Health stock for Q1 2023, up 31% quarter-over-quarter.
- 43 funds opened new Evolent Health positions in Q1 2023 and 33 closed out, a net change of +10 holders.
- The largest Evolent Health buyer in Q1 2023 was Fidelity Investments, an estimated $316M added.
- The largest Evolent Health seller in Q1 2023 was Point72 Asset Management, an estimated $93.7M sold.
Based on aggregated 13F filings for Q1 2023.